SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001140361-21-019839
Filing Date
2021-06-04
Accepted
2021-06-04 12:21:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 nt10023650x5_424b3.htm 424B3 346398
2 logo_brooklyn.jpg GRAPHIC 97422
  Complete submission text file 0001140361-21-019839.txt   481702
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-256570 | Film No.: 21995622
SIC: 2834 Pharmaceutical Preparations